IO Biotech
IOBT
IOBT
18 hedge funds and large institutions have $59.6M invested in IO Biotech in 2023 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 4 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
25% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 4
Holders
18
Holding in Top 10
1
Calls
$1.86M
Puts
–
Top Buyers
| 1 | +$8.45M | |
| 2 | +$1.86M | |
| 3 | +$121K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$97.5K |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$24.4K |
Top Sellers
| 1 | -$2.84M | |
| 2 | -$1.39M | |
| 3 | -$581K | |
| 4 |
AC
Armistice Capital
New York
|
-$421K |
| 5 |
XT
XTX Topco
George Town,
Cayman Islands
|
-$29.3K |